Basel Medical Group Statistics
Total Valuation
BMGL has a market cap or net worth of $9.61 million. The enterprise value is $10.94 million.
| Market Cap | 9.61M |
| Enterprise Value | 10.94M |
Important Dates
The next estimated earnings date is Wednesday, November 4, 2026, before market open.
| Earnings Date | Nov 4, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
BMGL has 1.57 million shares outstanding. The number of shares has increased by 23.41% in one year.
| Current Share Class | 1.57M |
| Shares Outstanding | 1.57M |
| Shares Change (YoY) | +23.41% |
| Shares Change (QoQ) | -11.89% |
| Owned by Insiders (%) | 13.65% |
| Owned by Institutions (%) | 0.32% |
| Float | 501,419 |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.86 |
| Forward PS | n/a |
| PB Ratio | 2.12 |
| P/TBV Ratio | 2.01 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.95 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.88, with a Debt / Equity ratio of 1.51.
| Current Ratio | 1.88 |
| Quick Ratio | 1.81 |
| Debt / Equity | 1.51 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -13.46 |
Financial Efficiency
Return on equity (ROE) is -147.37% and return on invested capital (ROIC) is -54.56%.
| Return on Equity (ROE) | -147.37% |
| Return on Assets (ROA) | -15.46% |
| Return on Invested Capital (ROIC) | -54.56% |
| Return on Capital Employed (ROCE) | -34.41% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | $139,717 |
| Profits Per Employee | -$95,281 |
| Employee Count | 82 |
| Asset Turnover | 0.84 |
| Inventory Turnover | 58.65 |
Taxes
| Income Tax | -188,067 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -77.26% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -77.26% |
| 50-Day Moving Average | 7.32 |
| 200-Day Moving Average | 10.23 |
| Relative Strength Index (RSI) | 42.78 |
| Average Volume (20 Days) | 22,613 |
Short Selling Information
The latest short interest is 12,662, so 0.81% of the outstanding shares have been sold short.
| Short Interest | 12,662 |
| Short Previous Month | 314,368 |
| Short % of Shares Out | 0.81% |
| Short % of Float | 2.53% |
| Short Ratio (days to cover) | 0.09 |
Income Statement
In the last 12 months, BMGL had revenue of $11.46 million and -$7.81 million in losses. Loss per share was -$4.68.
| Revenue | 11.46M |
| Gross Profit | 1.60M |
| Operating Income | -3.37M |
| Pretax Income | -8.09M |
| Net Income | -7.81M |
| EBITDA | -3.15M |
| EBIT | -3.37M |
| Loss Per Share | -$4.68 |
Balance Sheet
The company has $6.57 million in cash and $7.67 million in debt, with a net cash position of -$1.11 million or -$0.71 per share.
| Cash & Cash Equivalents | 6.57M |
| Total Debt | 7.67M |
| Net Cash | -1.11M |
| Net Cash Per Share | -$0.71 |
| Equity (Book Value) | 5.07M |
| Book Value Per Share | 3.12 |
| Working Capital | 5.17M |
Cash Flow
In the last 12 months, operating cash flow was -$1.47 million and capital expenditures -$8.55 million, giving a free cash flow of -$9.98 million.
| Operating Cash Flow | -1.47M |
| Capital Expenditures | -8.55M |
| Depreciation & Amortization | 215,605 |
| Net Borrowing | 5.09M |
| Free Cash Flow | -9.98M |
| FCF Per Share | -$6.37 |
Margins
Gross margin is 14.01%, with operating and profit margins of -29.42% and -68.20%.
| Gross Margin | 14.01% |
| Operating Margin | -29.42% |
| Pretax Margin | -70.58% |
| Profit Margin | -68.20% |
| EBITDA Margin | -27.53% |
| EBIT Margin | -29.42% |
| FCF Margin | n/a |
Dividends & Yields
BMGL does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -23.41% |
| Shareholder Yield | -23.41% |
| Earnings Yield | -79.47% |
| FCF Yield | -101.47% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on June 22, 2026. It was a reverse split with a ratio of 1:12.
| Last Split Date | Jun 22, 2026 |
| Split Type | Reverse |
| Split Ratio | 1:12 |
Scores
BMGL has an Altman Z-Score of 2.89 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.89 |
| Piotroski F-Score | 3 |